Gallbladder cancer, a rare malignancy affecting the organ storing bile, often presents without early symptoms, leading to ...

Neighbors organized a car wash fundraiser to support 9-year-old Logan Coyle, a local boy who has faced unimaginable medical ...

“By uncovering specific genetic vulnerabilities like the CDS1 and CDS2 relationship, we’re opening the door to new therapies ...

Prostate cancer is a significant health concern for men globally, with rising incidence and mortality rates. Early detection ...

The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...

Application error: a client-side exception has occurred (see the browser console for more information).

The latest research published in Genes & Diseases unveils groundbreaking insights into the role of the aging process and the ...

The latest research published in Genes & Diseases unveils groundbreaking insights into the role of the aging process and the ...

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

Each year, it is estimated more than 40,000 people will be diagnosed with liver cancer – and those numbers are increasing.

A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) ...